Evidence map›Paper›PMID 36482061›Full record

ArticleScientific reports2022

Synthesize of Bi

Asal Moradi, Mohammadreza Abdihaji, Sara Barari Kouchaksaraie, Tabarek Abdulrazaq Alkinani, Aida Mahmoudi, Arash Davoudi, William Dashtmiani, Somayeh Mikaeili Ghezeljeh, Shahrzad Aghajani, Reza Ghasemian and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Co-assembled structures of FeTranslational cancer research · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 4 countries.

Asal MoradiDepartment of Biology, Rasht Branch, Islamic Azad University, Rasht, Iran.
Mohammadreza AbdihajiDepartment of Biology, The Center for Genomics and Bioinformatics, Indiana University, Bloomington, IN, USA.
Sara Barari KouchaksaraieDepartment of Biology, Rasht Branch, Islamic Azad University, Rasht, Iran.
Tabarek Abdulrazaq AlkinaniDepartment of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Aida MahmoudiDepartment of Biology, Damghan Branch, Islamic Azad University, Damghan, Iran.
Arash DavoudiDepartment of Biology, Rasht Branch, Islamic Azad University, Rasht, Iran.
William DashtmianiCancer Research Laboratories, Department of Surgery, St. George Hospital, University of New South Wales, Sydney, NSW, 2217, Australia.
Somayeh Mikaeili GhezeljehDepartment of Biology, Rasht Branch, Islamic Azad University, Rasht, Iran.
Shahrzad AghajaniDepartment of Biology, Rasht Branch, Islamic Azad University, Rasht, Iran.
Reza GhasemianDepartment of Medical Sciences, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Somayeh Maghsoomi TaramsariMax Perutz Labs, Vienna Biocenter (VBC), Dr. Bohr-Gasse 9, University of Vienna, Vienna, Austria.
Amitis MajlesiDepartment of Biology, Rasht Branch, Islamic Azad University, Rasht, Iran.
Zahra Mahdavi NiyakiDepartment of Biology, Rasht Branch, Islamic Azad University, Rasht, Iran.
Ali SalehzadehDepartment of Biology, Rasht Branch, Islamic Azad University, Rasht, Iran. salehzadeh@iaurasht.ac.ir.
Islamic Azad University Rasht Branch · IRIndiana University Bloomington · USIslamic Azad University, Damghan Branch · IRIslamic Azad University Medical Branch of Tehran · IRIslamic Azad University, Science and Research Branch · IRMax Perutz Labs · ATUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the high prevalence and considerable increase of prostate cancer, finding novel therapeutic compounds for the treatment of prostatic cancer has been the goal of many researches. In this study, we aimed to fabricate the Bismuth oxide (Bi

Indexed as

GlutamineProstatic NeoplasmsCaspase 3Caspase 8Genes, bcl-2HumansMaleSpectroscopy, Fourier Transform InfraredCASP8 protein, humanCaspase 3Caspase 8Glutamine

Identifiers

PMID36482061
PMCPMC9731994
OpenAlexW4311576961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.